WEBSITE BSE:543331 NSE: MOL Inc. Year: 2019 Industry: Pesticides & Agrochemicals
Last updated: 15:59
Meghmani Organics Ltd went out of commercial enterprise. Meghmani Organics Ltd engages in manufacturing and promoting pigment and agrochemicals merchandise. The corporation operates through three segments: Agro Chemicals, Pigment Business, and Basic Chemicals. The Agro Chemicals section offers technical, intermediates, and formulations of insecticides, fungicides, and herbicides, that are utilized in crop protection, public fitness, termite and insect manage, and veterinary packages. The Pigment Business segment provides phthalocynine green 7, ...Read More
Meghmani Organics Ltd went out of commercial enterprise. Meghmani Organics Ltd engages in manufacturing and promoting pigment and agrochemicals merchandise. The corporation operates through three segments: Agro Chemicals, Pigment Business, and Basic Chemicals. The Agro Chemicals section offers technical, intermediates, and formulations of insecticides, fungicides, and herbicides, that are utilized in crop protection, public fitness, termite and insect manage, and veterinary packages. The Pigment Business segment provides phthalocynine green 7, copper phthalocynine blue, alpha blue, and beta blue pigments that are utilized in diverse packages, along with printing inks, plastics, paints, textiles, leather-based, paper, and rubber. The Basic Chemicals section provides caustic chlorine and caustic potash, that are utilized by the agriculture quarter, industry, and immediately by the consumers. It is likewise in the buying and selling of pigment and chemical substances. The organisation mostly operates under the Megastar, Megacyper, Megaban, Synergy, Courage, Correct, and Mega Claim logo names. Meghmani Organics Ltd offers its products to customers thru direct sales groups and vendors/sellers in North America, Europe, Central and Latin America, the Asia Pacific, and the world over. The corporation was previously called Gujarat Industries. Meghmani Organics Ltd is primarily based in Ahmedabad, India. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹1358 Cr.
Stock P/E -128.1
P/B 0.9
Current Price ₹53.4
Book Value ₹ 60.4
Face Value 1
52W High ₹106
Dividend Yield 0%
52W Low ₹ 52.2
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 379 | 352 | 410 | 414 | 544 | 569 | 553 | 614 | 577 | 509 |
| Other Income | 12 | 10 | 9 | 9 | 12 | 9 | 14 | 17 | 28 | 15 |
| Total Income | 391 | 361 | 419 | 423 | 556 | 578 | 567 | 630 | 605 | 524 |
| Total Expenditure | 371 | 360 | 408 | 408 | 513 | 528 | 488 | 547 | 525 | 471 |
| Operating Profit | 20 | 2 | 11 | 15 | 43 | 50 | 79 | 83 | 80 | 53 |
| Interest | 13 | 27 | 2 | 11 | 26 | 13 | 19 | 29 | 24 | 18 |
| Depreciation | 23 | 23 | 23 | 23 | 25 | 30 | 29 | 30 | 30 | 30 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -16 | -48 | -14 | -19 | -9 | 7 | 31 | 24 | 26 | 5 |
| Provision for Tax | -0 | -10 | 4 | -3 | 0 | 12 | 11 | 12 | 15 | 8 |
| Profit After Tax | -15 | -38 | -18 | -17 | -9 | -4 | 20 | 13 | 12 | -4 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -0 |
| Profit After Adjustments | -15 | -38 | -18 | -17 | -9 | -4 | 20 | 13 | 12 | -4 |
| Adjusted Earnings Per Share | -0.6 | -1.5 | -0.7 | -0.7 | -0.4 | -0.2 | 0.8 | 0.5 | 0.5 | -0.1 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 700 | 1637 | 2498 | 2553 | 1566 | 2080 | 2253 |
| Other Income | 131 | 25 | 98 | 96 | 41 | 44 | 74 |
| Total Income | 830 | 1661 | 2596 | 2649 | 1607 | 2124 | 2326 |
| Total Expenditure | 595 | 1354 | 2120 | 2212 | 1587 | 1937 | 2031 |
| Operating Profit | 235 | 307 | 476 | 437 | 21 | 187 | 295 |
| Interest | 18 | 11 | 11 | 66 | 50 | 69 | 90 |
| Depreciation | 22 | 51 | 63 | 77 | 92 | 108 | 119 |
| Exceptional Income / Expenses | 0 | 7 | 6 | 19 | 0 | 0 | 0 |
| Profit Before Tax | 194 | 252 | 409 | 313 | -121 | 9 | 86 |
| Provision for Tax | 45 | 65 | 104 | 75 | -15 | 20 | 46 |
| Profit After Tax | 150 | 186 | 304 | 238 | -106 | -11 | 41 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 150 | 186 | 304 | 238 | -106 | -11 | 41 |
| Adjusted Earnings Per Share | 5.9 | 7.3 | 12 | 9.3 | -4.2 | -0.4 | 1.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 33% | -6% | 24% | 0% |
| Operating Profit CAGR | 790% | -27% | -4% | 0% |
| PAT CAGR | 0% | NAN% | NAN% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -33% | -18% | NA% | NA% |
| ROE Average | -1% | 3% | 10% | 11% |
| ROCE Average | 3% | 6% | 12% | 13% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 986 | 1173 | 1466 | 1669 | 1528 | 1515 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 56 | 123 | 209 | 402 | 383 | 283 |
| Other Non-Current Liabilities | 63 | 64 | 88 | 98 | 66 | 83 |
| Total Current Liabilities | 552 | 614 | 1035 | 1030 | 1062 | 1204 |
| Total Liabilities | 1657 | 1974 | 2798 | 3198 | 3039 | 3085 |
| Fixed Assets | 481 | 634 | 911 | 1166 | 1152 | 1575 |
| Other Non-Current Assets | 324 | 346 | 451 | 567 | 675 | 160 |
| Total Current Assets | 853 | 995 | 1436 | 1466 | 1212 | 1350 |
| Total Assets | 1657 | 1974 | 2798 | 3198 | 3039 | 3085 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 8 | 21 | 10 | 31 | 17 |
| Cash Flow from Operating Activities | 22 | 333 | 65 | 204 | 250 | 66 |
| Cash Flow from Investing Activities | -3 | -307 | -133 | -418 | -178 | 31 |
| Cash Flow from Financing Activities | -26 | -14 | 58 | 234 | -85 | -91 |
| Net Cash Inflow / Outflow | -8 | 12 | -10 | 21 | -14 | 6 |
| Closing Cash & Cash Equivalent | 8 | 21 | 10 | 31 | 17 | 23 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 5.88 | 7.33 | 11.97 | 9.35 | -4.17 | -0.42 |
| CEPS(Rs) | 6.76 | 9.33 | 14.43 | 12.38 | -0.54 | 3.84 |
| DPS(Rs) | 0 | 1.4 | 1.4 | 1.4 | 0 | 0 |
| Book NAV/Share(Rs) | 38.79 | 46.13 | 57.65 | 65.64 | 60.07 | 59.58 |
| Core EBITDA Margin(%) | 14.79 | 17.09 | 15.04 | 13.23 | -1.27 | 6.77 |
| EBIT Margin(%) | 30.2 | 15.91 | 16.68 | 14.7 | -4.48 | 3.74 |
| Pre Tax Margin(%) | 27.6 | 15.24 | 16.24 | 12.15 | -7.6 | 0.45 |
| PAT Margin (%) | 21.26 | 11.28 | 12.1 | 9.22 | -6.65 | -0.5 |
| Cash Profit Margin (%) | 24.44 | 14.35 | 14.59 | 12.21 | -0.87 | 4.62 |
| ROA(%) | 9.03 | 10.27 | 12.76 | 7.93 | -3.4 | -0.35 |
| ROE(%) | 15.16 | 17.27 | 23.07 | 15.16 | -6.63 | -0.7 |
| ROCE(%) | 17 | 19.59 | 24.73 | 17.02 | -2.94 | 3.35 |
| Receivable days | 239.14 | 96.26 | 69.15 | 75.5 | 109.43 | 86.49 |
| Inventory Days | 157.47 | 75.05 | 73.63 | 91.42 | 133.77 | 96.58 |
| Payable days | 209.36 | 116.01 | 114.77 | 123.53 | 167.63 | 150.52 |
| PER(x) | 0 | 0 | 8.71 | 8.3 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 1.81 | 1.18 | 1.32 | 1.03 |
| Dividend Yield(%) | 0 | 0 | 1.34 | 1.8 | 0 | 0 |
| EV/Net Sales(x) | 0.4 | 0.16 | 1.25 | 1.08 | 1.81 | 1.13 |
| EV/Core EBITDA(x) | 1.19 | 0.87 | 6.58 | 6.32 | 135.97 | 12.61 |
| Net Sales Growth(%) | 0 | 133.96 | 52.66 | 2.17 | -38.64 | 32.78 |
| EBIT Growth(%) | 0 | 23.77 | 59.63 | -9.76 | -118.85 | 210.44 |
| PAT Growth(%) | 0 | 24.67 | 63.25 | -21.91 | -144.6 | 90 |
| EPS Growth(%) | 0 | 24.67 | 63.25 | -21.92 | -144.6 | 90 |
| Debt/Equity(x) | 0.27 | 0.22 | 0.34 | 0.49 | 0.55 | 0.55 |
| Current Ratio(x) | 1.55 | 1.62 | 1.39 | 1.42 | 1.14 | 1.12 |
| Quick Ratio(x) | 0.99 | 1.01 | 0.77 | 0.79 | 0.65 | 0.62 |
| Interest Cover(x) | 11.62 | 23.5 | 38.16 | 5.76 | -1.43 | 1.14 |
| Total Debt/Mcap(x) | 0 | 0 | 0.19 | 0.42 | 0.41 | 0.53 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 49.32 | 49.32 | 49.32 | 49.32 | 49.33 | 49.33 | 49.41 | 48.98 | 48.98 | 48.98 |
| FII | 1.34 | 1.3 | 1.51 | 1.39 | 2.22 | 1.89 | 1.81 | 1.94 | 1.48 | 1.33 |
| DII | 0.65 | 0.3 | 0.24 | 0.24 | 0.46 | 0.3 | 0.53 | 0.41 | 0.04 | 0.04 |
| Public | 48.69 | 49.09 | 48.93 | 49.05 | 47.98 | 48.48 | 48.25 | 48.67 | 49.5 | 49.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 12.54 | 12.54 | 12.54 | 12.54 | 12.54 | 12.55 | 12.57 | 12.46 | 12.46 | 12.46 |
| FII | 0.34 | 0.33 | 0.38 | 0.35 | 0.57 | 0.48 | 0.46 | 0.49 | 0.38 | 0.34 |
| DII | 0.17 | 0.08 | 0.06 | 0.06 | 0.12 | 0.08 | 0.13 | 0.1 | 0.01 | 0.01 |
| Public | 12.38 | 12.48 | 12.44 | 12.47 | 12.2 | 12.33 | 12.27 | 12.38 | 12.59 | 12.63 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
